Sandra Pérez-Ramos

5PUBLICATIONS
44CO-AUTHORS
ChemotherapyPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 29, 2026
Author Correction: The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2.

|Jan 01, 2026
Immunosuppressive macrophages determine the effect of cellular senescence on tumor progression.

Marta Lalinde-Gutiérrez, Sandra Pérez-Ramos, Verónica Rodilla

|Nov 18, 2024
Generation of chimeric antigen receptor T cells targeting p95HER2 in solid tumors.

Macarena Román Alonso, Ariadna Grinyó-Escuer, Santiago Duro-Sánchez

|Jan 24, 2024
The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2.

Selim Chaib, José Alberto López-Domínguez, Marta Lalinde-Gutiérrez

|Oct 12, 2022
Therapy-Induced Senescence Enhances the Efficacy of HER2-Targeted Antibody-Drug Conjugates in Breast Cancer.

Santiago Duro-Sánchez, Mercedes Nadal-Serrano, Marta Lalinde-Gutiérrez

Pageof 1

Frequent Collaborators

5 joint publications

Joaquín Arribas

4 joint publications

Marta Lalinde-Gutiérrez

2 joint publications

Santiago Duro-Sánchez

2 joint publications

Andrea García-Garijo